04-10-2014
Company launches Cancer Research Consortium among leading cancer research centers and Universities in the MENA region. The consortium will be lead by a scientific committee from doctors at leading USA and European Universities and Medical Centers and who originated from the MENA region.
10-10-2012
Avicemer and Asterand execute a master agreement for research collaboration to support The Cancer Genome Atlas (TCGA) project.
06-28-2010
Riyadh, Saudi Arabia, Arabio, (www.arabio.com) one of the leading biopharmaceutical companies in MENA region executes an LOI for collaboration and co-development of biopharmaceutical products with Avicemer parent company, MPR.
12-10-2009
Company in collaboration with several MOH’s in MENA and Gulf region to administer to distribution of Peramivir to treat H1N1 flu vaccine under emergency use and special process approval. The Company in collaboration with BioCryst Pharmaceutical Inc. and several regulatory agencies are making the drug available for the treatment of H1N1 during the flu season.
11-30-2009
Company and Yamamoto Co. launch a joint research and development project to expand the application and use of Hyperthermia in the treatment of several indications of cancer using an innovative medical device, Thermotron-RF8. Thermotron-RF8 is a clinical Hyperthermia system that uses 8 MHz RF waves.
07-27-2009
Algeria
Company expands early phases clinical studies capabilities to Morocco, expands to Algeria and appoints Dr. Karim Jamali as a regional director.
06-06-2008
Dubai, UAE
Company launches 11 risk sharing clinical programs in affiliation with leading investment banks in Dubai and in coordination with USA pharma sponsors. The programs are in early and late phase developments for the treatment of AD, Diabetes, Heart Attack and PD.
03-23-2008
UAE
Avicemer partners with Julphar Pharmaceutical Industries in UAE for the joint development of novel drugs.
05-04-2007
Tunisia
Set up a subsidiary in Tunisia as a scientific office managing company’s business for drug developments and marketing and commercialization of medical products. The Company nominated Dr. Emna Kotran-Ayari as the director to lead subsidiary BOD.
02-09-2007
Company co-sponsor Rabat Health & Clinical Research Conference sponsored by Morocco Ministry of Health. Company CEO and BOD director for CNS research are key note speakers.
